These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 26768065)
21. [Prognosis and treatment of Vernal keratoconjunctivitis in pediatric age: pilot study on 197 patients]. Spadavecchia L; Fanelli P; Tesse R; Rizzo G; Procoli U; Bellizzi M; Armenio L Minerva Pediatr; 2010 Jun; 62(3):239-44. PubMed ID: 20467374 [TBL] [Abstract][Full Text] [Related]
22. [Efficacy of topical 2% cyclosporine A as a steroid-sparing agent in steroid-dependent vernal keratoconjunctivitis]. Doan S; Gabison E; Abitbol O; Gatinel D; Chast F; Hoang-Xuan T J Fr Ophtalmol; 2007 Sep; 30(7):697-701. PubMed ID: 17878822 [TBL] [Abstract][Full Text] [Related]
23. Efficacy of 2% Rebamipide Suspension for Vernal Keratoconjunctivitis: A Clinical Comparison with Topical Immune Modulators Cyclosporine and Tacrolimus. Malhotra C; Singh H; Jain AK; Gupta A; Ram J Ocul Immunol Inflamm; 2022 Jul; 30(5):1083-1091. PubMed ID: 33764241 [TBL] [Abstract][Full Text] [Related]
24. Treatment of severe vernal keratoconjunctivitis with 1% topical cyclosporine in an Italian cohort of 197 children. Tesse R; Spadavecchia L; Fanelli P; Rizzo G; Procoli U; Brunetti L; Cardinale F; Miniello VL; Bellizzi M; Armenio L Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 1):330-5. PubMed ID: 19840298 [TBL] [Abstract][Full Text] [Related]
25. Efficacy of Topical Cyclosporine 0.05% the Treatment of Vernal Keratoconjunctivitis. Subedi K; Sharma B; Shrestha S Nepal J Ophthalmol; 2020 Jan; 12(23):39-47. PubMed ID: 32799238 [TBL] [Abstract][Full Text] [Related]
26. Twelve-Month Results of Cyclosporine A Cationic Emulsion in a Randomized Study in Patients With Pediatric Vernal Keratoconjunctivitis. Bremond-Gignac D; Doan S; Amrane M; Ismail D; Montero J; Németh J; Aragona P; Leonardi A; Am J Ophthalmol; 2020 Apr; 212():116-126. PubMed ID: 31770513 [TBL] [Abstract][Full Text] [Related]
27. Corneal Microstructural Changes by Confocal Microscopy in Vernal Keratoconjunctivitis Patients Treated with Topical Cyclosporine. Modugno RL; Scalora T; Bonaldo A; Lazzarini D; Leonardi A Ocul Immunol Inflamm; 2021 Nov; 29(7-8):1599-1605. PubMed ID: 32275180 [No Abstract] [Full Text] [Related]
30. Eyelash length in children with vernal keratoconjunctivitis: effect of treatment with cyclosporine eye drops. Pucci N; Massai C; Bernardini R; Caputo R; Mori F; De Libero C; Novembre E; De Martino M; Vierucci A Int J Immunopathol Pharmacol; 2007; 20(3):595-9. PubMed ID: 17880772 [TBL] [Abstract][Full Text] [Related]
31. A randomized, placebo-controlled trial of topical cyclosporin A in steroid-dependent atopic keratoconjunctivitis. Hingorani M; Moodaley L; Calder VL; Buckley RJ; Lightman S Ophthalmology; 1998 Sep; 105(9):1715-20. PubMed ID: 9754182 [TBL] [Abstract][Full Text] [Related]
32. Efficacy of 1.25% and 1% topical cyclosporine in the treatment of severe vernal keratoconjunctivitis in childhood. Spadavecchia L; Fanelli P; Tesse R; Brunetti L; Cardinale F; Bellizzi M; Rizzo G; Procoli U; Bellizzi G; Armenio L Pediatr Allergy Immunol; 2006 Nov; 17(7):527-32. PubMed ID: 17014629 [TBL] [Abstract][Full Text] [Related]
33. Therapeutic Effect of 0.1% Tacrolimus Eye Drops in the Tarsal Form of Vernal Keratoconjunctivitis. Wan Q; Tang J; Han Y; Wang D; Ye H Ophthalmic Res; 2018; 59(3):126-134. PubMed ID: 28803239 [TBL] [Abstract][Full Text] [Related]
34. Role of ocular cytology in vernal keratoconjunctivitis. Bruschi G; Ghiglioni DG; Osnaghi S; Rosazza C; Pires Marafon D; Landi M; Marchisio PG Immun Inflamm Dis; 2020 Mar; 8(1):3-7. PubMed ID: 31804769 [TBL] [Abstract][Full Text] [Related]
35. Management of severe allergic conjunctivitis with topical cyclosporin a 0.05% eyedrops. Ozcan AA; Ersoz TR; Dulger E Cornea; 2007 Oct; 26(9):1035-8. PubMed ID: 17893529 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of retinal nerve fiber layer thickness in vernal keratoconjunctivitis patients under long-term topical corticosteroid therapy. Cingu AK; Cinar Y; Turkcu FM; Sahinoglu-Keskek N; Sahin A; Sahin M; Yuksel H; Caca I Cutan Ocul Toxicol; 2014 Sep; 33(3):184-8. PubMed ID: 24021018 [TBL] [Abstract][Full Text] [Related]
37. Topical cyclosporine a 1% for the treatment of chronic ocular surface inflammation. Ragam A; Kolomeyer AM; Kim JS; Nayak NV; Fang C; Kim E; Chu DS Eye Contact Lens; 2014 Sep; 40(5):283-8. PubMed ID: 25083780 [TBL] [Abstract][Full Text] [Related]
38. Applications of topical immunomodulators enhance clinical signs of vernal keratoconjunctivitis (VKC) and atopic keratoconjunctivitis (AKC): a meta-analysis. Erdinest N; Noyman DBE; London N; Lavy I; Levinger N; Landau D; Solomon A; Morad Y; Naroo SA Int Ophthalmol; 2024 Mar; 44(1):157. PubMed ID: 38522059 [TBL] [Abstract][Full Text] [Related]
39. Topical cyclosporine a in the treatment of superior limbic keratoconjunctivitis: a long-term follow-up. Sahin A; Bozkurt B; Irkec M Cornea; 2008 Feb; 27(2):193-5. PubMed ID: 18216575 [TBL] [Abstract][Full Text] [Related]
40. Topical tacrolimus for the treatment of severe allergic keratoconjunctivitis in children. Liendo VL; Vola ME; Barreiro TP; Wakamatsu TH; Gomes JÁP; Santos MSD Arq Bras Oftalmol; 2017; 80(4):211-214. PubMed ID: 28954018 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]